Cargando…
Oral Pirfenidone in patients with chronic fibrosis resulting from radiotherapy: a pilot study
BACKGROUND: Fibrosis is a common side effect after treatment with ionizing radiation. Several methods to ameliorate debilitating fibrosis have been employed but without consistent results. The goal of this pilot study is to determine if Pirfenidone, a novel regulator of cytokine gene expression, has...
Autores principales: | Simone, Nicole L, Soule, Benjamin P, Gerber, Lynn, Augustine, Elizabeth, Smith, Sharon, Altemus, Rosemary M, Mitchell, James B, Camphausen, Kevin A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1891306/ https://www.ncbi.nlm.nih.gov/pubmed/17540023 http://dx.doi.org/10.1186/1748-717X-2-19 |
Ejemplares similares
-
Pirfenidone treatment of idiopathic pulmonary fibrosis
por: Gan, Ye, et al.
Publicado: (2011) -
Role of pirfenidone in the management of pulmonary fibrosis
por: Meyer, Keith C, et al.
Publicado: (2017) -
Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond
por: Aimo, Alberto, et al.
Publicado: (2022) -
The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis
por: Cottin, Vincent
Publicado: (2013) -
Efficacy and safety of pirfenidone for idiopathic pulmonary fibrosis
por: Takeda, Yoshito, et al.
Publicado: (2014)